HCA Healthcare (HCA) is under scrutiny after revising its full year 2026 earnings guidance downward, citing a less favorable payer mix and more uninsured patient visits, along with a new securities fraud investigation.

At a share price of $376.50, HCA Healthcare has seen the share price fall over the past quarter and year to date, even though the 1 year total shareholder return is 11.00% and the 5 year total shareholder return is 58.38%. This indicates that longer term holders have still seen positive gains despite recent pressure following the guidance cut and investigation headlines.

If you are weighing up HCA Healthcare alongside other opportunities in the sector, this could be a good moment to see what else is happening in healthcare related AI by checking out 39 healthcare AI stocks

After the guidance cut, investigation headlines and a share price that is down year to date, should you treat the current level in HCA Healthcare as a reasonable entry, or hold off in case the valuation resets further?

Most Popular Narrative: 40.2% Undervalued

According to the most followed narrative on HCA Healthcare, a fair value of $629.14 sits well above the last close at $376.50. This puts a spotlight on what is driving that gap.

In a market that often swings between hype and fear, HCA Healthcare (NYSE: HCA) is highlighted for a different reason: consistency. While much of the healthcare sector wrestles with reimbursement uncertainty, labor costs, and regulatory noise, HCA continues to operate from a position of scale and operational discipline. It is not flashy, but it is effective.

Want to see why this narrative still supports a materially higher fair value for HCA Healthcare? The core assumptions focus on steady revenue trends, disciplined margins, and an earnings profile that relies more on execution than on headline growth.

Result: Fair Value of $629.14 (UNDERVALUED)

However, investors also need to keep an eye on the securities fraud investigation and any further shift toward uninsured patients that pressures HCA Healthcare’s payer mix and earnings.

Next Steps

With sentiment split between concern over risks and optimism about rewards for HCA Healthcare, this is a moment to review the numbers yourself and move quickly to form your own view using the 4 key rewards and 2 important warning signs.

Looking for more investment ideas beyond HCA Healthcare?

If HCA Healthcare has sharpened your focus, do not stop here. Broaden your watchlist with other focused stock ideas that could sharpen your overall portfolio.

• Target robust value potential by scanning companies that currently look mispriced using the 38 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies offering sizeable yields and consistent payouts through the 7 dividend fortresses.
• Protect your downside by filtering for companies with resilient finances and lower overall risk profiles via the 79 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.